We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byTaryn Ventre
Modified about 1 year ago
Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials by Nathalie Mourad, Nicolas Mounier, Josette Brière, Emmanuel Raffoux, Alain Delmer, Alfred Feller, Chris J. L. M. Meijer, Jean-François Emile, Réda Bouabdallah, André Bosly, Jacques Diebold, Corinne Haioun, Bertrand Coiffier, Christian Gisselbrecht, and Philippe Gaulard Blood Volume 111(9): May 1, 2008 ©2008 by American Society of Hematology
Histopathologic spectrum of AITL and patterns of CXCL13 expression. Nathalie Mourad et al. Blood 2008;111: ©2008 by American Society of Hematology
Survival of the 156 patients with angioimmunoblastic T-cell lymphoma. Nathalie Mourad et al. Blood 2008;111: ©2008 by American Society of Hematology
Overall survival of angioimmunoblastic T-cell lymphoma patients. Nathalie Mourad et al. Blood 2008;111: ©2008 by American Society of Hematology
Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men by Bas de Laat, Philip G. de Groot, Ronald H.
Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique by Caroline Cheng, Rien van Haperen, Monique.
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL by Arian.
Baseline Characteristics According to CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:
Statin Landmark Trials Across the Spectrum of Risk: Secondary CV Prevention.
Progress Against Lymphoma. 1970–1979 Progress Against Lymphoma 1970– : FDA approves doxorubicin, a vital part of combination chemotherapy.
Follicular Lymphoma Transformed Lymphoma Diffuse Large B-Cell Lymphoma John P. Leonard, M.D. Richard T. Silver Distinguished Professor of Hematology and.
The WHO Classification of Hematological Malignancies Pathology Grand Rounds April
Progress Against Kidney Cancer. 1970–1979 Progress Against Kidney Cancer 1970– : Removing just part of the cancerous kidney is proven safe and.
Barts Cancer Institute Rebecca Auer Waldenstrom’s: The Future.
Contemporary practice of radiotherapy post radical prostatectomy at a tertiary referral centre in Australia Introduction Adverse features on histopathology.
Vervolg CASUS. september inmiddels 6 kuren R-CVP ondergaan -restadiering: PR EN NU?
Results of COMFORT-I, a Randomized Double-Blind, Phase III Trial of JAK1/JAK2 Inhibitor Ruxolitinib (INCB18424) vs Placebo for Patients with Myelofibrosis.
Mark Pletcher 6/9/2011 Prognostic and Genetic Tests.
GRADO INTERMEDIO Dfollicolare, prevalenza di grandi cellule Ediffuso, a piccole cellule clivate Fdiffuso, misto a piccole e grandi cellule Gdiffuso a grandi.
1 Sjögren‘s Syndrome 1.Ocular symptoms 2.Oral symptoms 3.Ocular signs 4.Histopathology 5.Salivary gland involvement 6.Autoantibodies In patients without.
Measuring Angiogenesis in Hematologic Diseases Maher Albitar, MD Quest Diagnostics, Nichols Institute San Juan Capistrano, CA (949)
Additional file 3 3.1Summary of proteins identified using Spectrum Mill and Mascot 3.2Venn diagram of proteins commonly or uniquely identified using Spectrum.
CLINICAL AND BIOLOGICAL FACTORS WITH PROGNOSTIC VALUE IN PRIMARY SPLENIC LYMPHOMA First Author: Vanga Carmen Adina Author: Hutu Simona Botoman Maria Muresan.
Food Allergies: Whats New in Clinical, Community, School and Food Service Applications Janice M. Joneja, Ph.D., RD 2006.
HODGKIN LYMPHOMA IN CHILDREN Dr.M.Shamvil Ashraf Children Cancer Hospital, Karachi.
Non-Hodgkin’s Lymphoma Luis Fayad, MD Assistant Professor Clinical Medical Director Lymphoma/Myeloma Department.
Sibbing D, et al. J Am Coll Cardiol 2009;53:
Supplemental figure 1 ROS production in MM cell line (KMM1) treated with bortezomib and DCA. ROS production was marginally increased by DCA in combination.
Presented by Ke-Yong Shi StemEx ® from Research to Clinical Trial.
TBW2006 Geriatrisk avdeling Ullevål universitetssykehus ACCESS-studien Acute Candesartan Cilexetil Therapy in Stroke Survivors Schrader et al. Stroke 2003.
Best Practices in Research Collaborations Cancer Research in Africa Building Trans-national Research collaborations Martine RAPHAEL AfrOx – AORTIC/OAREC.
Pertuzumab in Combination with Trastuzumab and Docetaxel in Elderly Patients with HER2-Positive Metastatic Breast Cancer in the CLEOPATRA Study Miles D.
The World Society of the Abdominal Compartment Syndrome (www.wsacs.org) presents.
© 2016 SlidePlayer.com Inc. All rights reserved.